CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,645 shares (to pay taxes)
- 4 Shares withheld for taxes President and COO gave up 4,361 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 2,747 shares (to pay taxes)
- 4/A Derivatives Options or other derivatives
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and COO gave up 10,366 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 10,648 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 8,325 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 20,515 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes CFO and Treasurer gave up 27,453 shares (to pay taxes)
- 4 Shares withheld for taxes President and COO gave up 26,823 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 15,702 shares (to pay taxes)
Page 3 of 34 · 670 filings